These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1700012)
1. In vivo immune selection of a Moloney murine leukemia virus-induced tumor results in the loss of viral- but not tumor-associated antigens. Jiang D; Flyer DC J Immunol; 1990 Nov; 145(10):3502-6. PubMed ID: 1700012 [TBL] [Abstract][Full Text] [Related]
2. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection. Jiang D; Flyer DC J Immunol; 1992 Feb; 148(3):974-80. PubMed ID: 1730885 [TBL] [Abstract][Full Text] [Related]
3. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens. Flyer DC; Burakoff SJ; Faller DV J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152 [TBL] [Abstract][Full Text] [Related]
4. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes. Flyer DC; Burakoff SJ; Faller DV J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792 [TBL] [Abstract][Full Text] [Related]
5. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens. Ng AK; Ames RS; McIntire RK; Herberman RB Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218 [TBL] [Abstract][Full Text] [Related]
6. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV). Zanovello P; Collavo D; Ronchese F; De Rossi A; Biasi G; Chieco-Bianchi L Immunology; 1984 Jan; 51(1):9-16. PubMed ID: 6228521 [TBL] [Abstract][Full Text] [Related]
7. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo. Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422 [TBL] [Abstract][Full Text] [Related]
8. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells. Green WR J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998 [TBL] [Abstract][Full Text] [Related]
9. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen. Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053 [TBL] [Abstract][Full Text] [Related]
10. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state. Weinhold KJ; Wheelock EF Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603 [TBL] [Abstract][Full Text] [Related]